In this episode, we hear from, Rich Brancaccio, Chief Innovation Officer of Revibe Technologies, and Lindsay Ayearst, Chief Scientific Officer of Revibe Technologies.
In their own words, Revibe is a digital therapeutics company fusing behavioral science with technology and currently developing a new digital therapy for ADHD.
In this episode, we cover:
- Founding story and funding milestones
- Child and caregiver experience using Revibe
- Quantifying attention & capturing focus data
- Evidence generation journey & clinical endpoints
- The ADHD market choice to focus on adolescent ADHD
- Lessons learned from the first wave of similar products and companies
- OTC vs PDT
Guest Links and Resources:
- Connect with Lindsay Ayearst on LinkedIn
- Connect with Rich Brancaccio on LinkedIn
- Visit www.revibetech.com
Host Links:
- Connect with Eugene Borukhovich: Twitter | LinkedIn
- Connect with Chandana Fitzgerald, MD: Twitter | LinkedIn
- Connect with YourCoach.health: Website | Twitter
- Check out Shot of Digital Health with Eugene and Jim Joyce: Website | Podcast App
- HealthXL: Website | Twitter | Join an Event
Digital Therapeutics Podcast would not be possible without the support of leading DTx organizations. Thank you to:
> Presenting Partner: Amalgam Rx
> Contributing Partners and Sponsors: LSI | Bayer G4A | Lindus Health
Follow Digital Health Today:
Browse Episodes | Twitter | LinkedIn | Facebook | Instagram
Follow Health Podcast Network:
Browse Shows | LinkedIn | Twitter | Facebook | Instagram
